A New Jersey firm backed by $750,000 from the California stem cell agency today announced that the California location of its Covid-19 trial will be at UC Irvine.
The firm is Celularity, Inc., and its proposed therapy is supported by Rudi Giuliani, President Trump's personal lawyer. Celularity expects to complete its work by Nov. 30.
CIRM said the research involves "a phase I/II study of human placental hematopoietic stem cell derived natural killer
cells for the treatment of adults with COVID-19."
The award was made June 26 by the agency's governing board, which expected its Covid grantees to be ready to start work within 30 days under its fast-track Covid round. Celularity had not responded to questions about the trial location prior to its news release today. The stem cell agency cannot fund research outside of California.
The company's news release indicated there would be more locations in California, but did not disclose any.
The UC Irvine work will be overseen by Leonid Groysman, a neurologist. Here is a link to a summary of the review of Celularity's application (CLIN2COVID19-11857 #2).
No comments:
Post a Comment